Science & Medicine
The experiment was so elementary, and the results so surprising, that researchers working with San Diego’s Vical Inc. couldn’t really believe what they were seeing.
March 23, 1990
Business
Vical Inc. shares soared on news that Merck & Co. will soon begin human tests of an AIDS vaccine that uses DNA technology developed by Vical.
July 31, 1999
A San Diego biotechnology company said Monday that it hoped to begin human testing of its experimental anthrax vaccine by year’s end.
March 11, 2003
Technology and the Internet
Vical, a new San Diego biotechnology company focusing on the development of drugs for the treatment of AIDS, herpes and other viral diseases, has received $2.5 million in venture capital from a group of firms and has hired Wick Goodspeed as president.
Sept. 29, 1988
Vical Inc., a San Diego biotechnology company developing infectious-disease treatments, said it signed an agreement with the U.S. to manufacture an experimental SARS vaccine.
Oct. 14, 2003
San Diego-based Vical Inc. said it won a patent for its new injection system of genes that stimulate disease-fighting proteins.
Dec. 4, 1996
Vical Inc. shares rose 10% after the company reported strong results from a 20-patient trial of its potential prostate cancer drug called Leuvectin.
June 2, 1998
Two years ago, as fears of a SARS pandemic spread, a San Diego biotech company aided by federal dollars speeded a promising vaccine out of the lab and into human testing.
Dec. 5, 2005
Archives
More and more, boutiques at South Coast Plaza are becoming part of Orange County’s social scene.
Feb. 20, 1992
California
A metal company has agreed to pay between $50,000 and $75,000 to clean up contaminated Buckeye Creek, the Orange County district attorney’s office announced Tuesday.
Dec. 2, 1992